WuXi Biologics has entered into a strategic partnership Letter of Intent (LOI) with a global vaccine leader, under which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market. WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology. This business model aims to build world-class integrated platforms and CDMO model to enable global companies to develop and manufacture vaccines. Unde...